While the molecular mechanisms remain unclear, increased ROS is associated with multiple aspects of the metabolic syndrome including obesity, fatty liver disease, and diabetes, and is thus an attractive therapeutic target to improve insulin sensitivity. The gene discussed is INS; the disease is metabolic syndrome.